3 stories found
Major companies including AbbVie, Johnson & Johnson, and Verizon presented growth strategies and pipeline updates at recent healthcare and technology conferences. Investors focused on AI integration and medtech resets during these events.
Analysts have identified several undervalued stocks to buy and hold for two years, including Biomarin Pharmaceutical and Block. Additionally, DHI Group and Velo3D are among the hot tech stocks recommended by analysts.
Several companies, including Yalla, Bally's Corporation, Agilysys, and Brady, have announced their latest quarterly financial results. Many reported earnings per share and revenue that either beat or missed analyst expectations.